The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

Sarepta has refused to suspend all dosing of its gene therapy for Duchenne muscular dystrophy, Elevidys, defying a clinical ...

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an unrelated drug.

In light of recent patient deaths, the FDA has also revoked its platform designation for Sarepta’s AAVrh74 technology. The ...

Sarepta stock took another dive Monday after the biotech company refused the FDA's request to voluntarily stop all shipments ...

The ground shook for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) last week as the U.S. Food and Drug Administration (FDA), ...

Sarepta stock (SRPT) declined 5% in premarket trade, after falling 36% on Friday, when it disclosed a patient death due to liver failure.

A disabled Oasis fan has described the 'biblical' scenes at Manchester's Heaton Park as other fans in the accessible area abandoned their crutches when the Gallagher brothers took to the stage.

Most investors don’t see the drugmaker’s executive management as credible, following the failure to disclose a patient death, ...

A disabled Oasis fan was horrified when dozens of fans in an accessible area at one of the band’s Manchester gigs ditched their wheelchairs ...

A disabled Oasis fan was horrified when dozens of 'wheelchair using' fans in an accessible area at Heaton Park stood up for the concert.

Drugmaker Sarepta Therapeutics said late Friday it won't comply with a request from the Food and Drug Administration to halt ...